Compare GameStop Corp. (GME) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GameStop Corp. vs Natera Inc. Common Stock — how do they compare? GameStop Corp. trades at $26.59 (market cap $13.73B), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 4.2× GameStop Corp.'s market cap, and GameStop Corp. is more actively traded (12,710,661 versus 1,131,157). Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 62 Days and Natera Inc. Common Stock for 0 Days on average.
| GME | NTRA | |
|---|---|---|
Market Cap | $13.73B | $57.03B |
Volume | 12,710,661 | 1,131,157 |
Sector | Consumer Cyclical | Health |
52-Week High | $27.23 | $425.64 |
52-Week Low | $17.87 | $179.42 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $13.01B | $56.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GME trades at $27.22, down slightly by 0.04% on the day. The stock shows strong technical momentum with bullish moving averages and positive price action near resistance at $28. Fundamentally, the company reported net income of $131.3 million in 2025 with improving profit margins of 25.16%, though revenue declined to $3.82 billion. Recent insider buying by CEO Ryan Cohen and directors has driven positive sentiment, with multiple purchases totaling over $26 million in September 2026.
GME presents a mixed outlook with strong insider confidence but challenging fundamentals. The investment opportunity lies in continued operational turnaround and potential strategic moves, while risks include revenue declines, competitive pressures in retail gaming, and the stock's meme stock volatility. Analyst consensus remains cautious with only 16.7% buy ratings versus 27.8% sells.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GameStop Corp.
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
